SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: jeff lipschutz who wrote (12262)7/29/1998 5:03:00 PM
From: AlienTech  Read Replies (1) | Respond to of 23519
 
pfizer would never buy them, It would be as good as telling the world viagra kills.
I would expect one of the distributors who would do it and who wants to expand into other markets, bsx? avei? best fit would be alza but I would think astra would like to get into something new. Heck its cheaper than trying to come up with something new that does not kill.
Heck its easy to copy something, but how many companies come out with new products that actually works better than the old with less problems? And I dont mean something thats addcitive, causes you to go blind and gives an itch.



To: jeff lipschutz who wrote (12262)7/29/1998 5:04:00 PM
From: Mark A. Stang  Respond to of 23519
 
Bought 30 Aug. 7 1/2 for $1,010. More fun than Powerball.